Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
July 2012, Vol 5, No 4
Business
Emerging Trends in Cancer Care: Health Plans’ and Pharmacy Benefit Managers’ Perspectives on Changing Care Models
Rhonda Greenapple, MSPH
,
Gary M. Owens, MD
Read More
Clinical
Chemotherapy-Induced Nausea and Vomiting: Optimizing Prevention and Management
Kamakshi V. Rao, PharmD, BCOP, CPP
,
Aimee Faso, PharmD, BCOP, CPP
Stakeholder Perspective
Selecting Best Therapies for Control of Chemotherapy-Induced Nausea and Vomiting
Read More
Clinical
Diabetes Medications and Cancer Risk: Review of the Literature
Lindsay Sanders, DO, MPH
,
Anu P. Michael, MD
,
Scott R. Anderson, MS IV
,
Loida D. Nguyen, PharmD, BCPS
,
Zackary A. Johnson, MS II
,
Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Cancer Risk Associated with Antidiabetes Medications: Implications for Patients, Providers, and Payers
by
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Cancer: Exploding Treatment and Diagnostic Pipeline, and Ever-Increasing Costs
Craig K. Deligdish, MD
Read More
Perspectives
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report
Read More
Results 1 - 5 of 5